Abstract

Stereotactic body radiation therapy (SBRT) has found an important role in the treatment of patients with non-small cell lung cancer, demonstrating improvements in dose distribution and even tumor cure rates, particularly for early-stage disease. Despite its emerging clinical efficacy, SBRT has primarily evolved due to advances in medical imaging and more accurate dose delivery, leaving a void in knowledge of the fundamental biological mechanisms underlying its activity. Thus, there is a critical need for the development of orthotropic animal models to further probe the biology associated with high-dose-per-fraction treatment typical of SBRT. We report here on an improved surgically based methodology for generating solitary intrapulmonary nodule tumors, which can be treated with simulated SBRT using the X-RAD 225Cx small animal irradiator and Small Animal RadioTherapy (SmART) Plan treatment system. Over 90% of rats developed solitary tumors in the right lung. Furthermore, the tumor response to radiation was monitored noninvasively via bioluminescence imaging (BLI), and complete ablation of tumor growth was achieved with 36 Gy (3 fractions of 12 Gy each). We report a reproducible, orthotopic, clinically relevant lung tumor model, which better mimics patient treatment regimens. This system can be utilized to further explore the underlying biological mechanisms relevant to SBRT and high-dose-per-fraction radiation exposure and to provide a useful model to explore the efficacy of radiation modifiers in the treatment of non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)616-622
Number of pages7
JournalRadiation Research
Volume185
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

lungs
rats
radiation therapy
Radiotherapy
tumors
Lung
dosage
Neoplasms
Non-Small Cell Lung Carcinoma
animals
cancer
Radiation
bioluminescence
Therapeutics
animal models
nodules
radiation dosage
radiation
Diagnostic Imaging
biology

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation

Cite this

Zhang, Z., Wodzak, M., Belzile, O., Zhou, H., Sishc, B., Yan, H., ... Saha, D. (2016). Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy. Radiation Research, 185(6), 616-622. https://doi.org/10.1667/RR14382.1

Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy. / Zhang, Zhang; Wodzak, Michelle; Belzile, Olivier; Zhou, Heling; Sishc, Brock; Yan, Hao; Stojadinovic, Strahinja; Mason, Ralph P.; Brekken, Rolf A.; Chopra, Rajiv; Story, Michael D.; Timmerman, Robert; Saha, Debabrata.

In: Radiation Research, Vol. 185, No. 6, 01.06.2016, p. 616-622.

Research output: Contribution to journalArticle

Zhang Z, Wodzak M, Belzile O, Zhou H, Sishc B, Yan H et al. Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy. Radiation Research. 2016 Jun 1;185(6):616-622. https://doi.org/10.1667/RR14382.1
@article{bf9712c79e0643c5bf823a8b3a1f4fb5,
title = "Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy",
abstract = "Stereotactic body radiation therapy (SBRT) has found an important role in the treatment of patients with non-small cell lung cancer, demonstrating improvements in dose distribution and even tumor cure rates, particularly for early-stage disease. Despite its emerging clinical efficacy, SBRT has primarily evolved due to advances in medical imaging and more accurate dose delivery, leaving a void in knowledge of the fundamental biological mechanisms underlying its activity. Thus, there is a critical need for the development of orthotropic animal models to further probe the biology associated with high-dose-per-fraction treatment typical of SBRT. We report here on an improved surgically based methodology for generating solitary intrapulmonary nodule tumors, which can be treated with simulated SBRT using the X-RAD 225Cx small animal irradiator and Small Animal RadioTherapy (SmART) Plan treatment system. Over 90{\%} of rats developed solitary tumors in the right lung. Furthermore, the tumor response to radiation was monitored noninvasively via bioluminescence imaging (BLI), and complete ablation of tumor growth was achieved with 36 Gy (3 fractions of 12 Gy each). We report a reproducible, orthotopic, clinically relevant lung tumor model, which better mimics patient treatment regimens. This system can be utilized to further explore the underlying biological mechanisms relevant to SBRT and high-dose-per-fraction radiation exposure and to provide a useful model to explore the efficacy of radiation modifiers in the treatment of non-small cell lung cancer.",
author = "Zhang Zhang and Michelle Wodzak and Olivier Belzile and Heling Zhou and Brock Sishc and Hao Yan and Strahinja Stojadinovic and Mason, {Ralph P.} and Brekken, {Rolf A.} and Rajiv Chopra and Story, {Michael D.} and Robert Timmerman and Debabrata Saha",
year = "2016",
month = "6",
day = "1",
doi = "10.1667/RR14382.1",
language = "English (US)",
volume = "185",
pages = "616--622",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "6",

}

TY - JOUR

T1 - Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy

AU - Zhang, Zhang

AU - Wodzak, Michelle

AU - Belzile, Olivier

AU - Zhou, Heling

AU - Sishc, Brock

AU - Yan, Hao

AU - Stojadinovic, Strahinja

AU - Mason, Ralph P.

AU - Brekken, Rolf A.

AU - Chopra, Rajiv

AU - Story, Michael D.

AU - Timmerman, Robert

AU - Saha, Debabrata

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Stereotactic body radiation therapy (SBRT) has found an important role in the treatment of patients with non-small cell lung cancer, demonstrating improvements in dose distribution and even tumor cure rates, particularly for early-stage disease. Despite its emerging clinical efficacy, SBRT has primarily evolved due to advances in medical imaging and more accurate dose delivery, leaving a void in knowledge of the fundamental biological mechanisms underlying its activity. Thus, there is a critical need for the development of orthotropic animal models to further probe the biology associated with high-dose-per-fraction treatment typical of SBRT. We report here on an improved surgically based methodology for generating solitary intrapulmonary nodule tumors, which can be treated with simulated SBRT using the X-RAD 225Cx small animal irradiator and Small Animal RadioTherapy (SmART) Plan treatment system. Over 90% of rats developed solitary tumors in the right lung. Furthermore, the tumor response to radiation was monitored noninvasively via bioluminescence imaging (BLI), and complete ablation of tumor growth was achieved with 36 Gy (3 fractions of 12 Gy each). We report a reproducible, orthotopic, clinically relevant lung tumor model, which better mimics patient treatment regimens. This system can be utilized to further explore the underlying biological mechanisms relevant to SBRT and high-dose-per-fraction radiation exposure and to provide a useful model to explore the efficacy of radiation modifiers in the treatment of non-small cell lung cancer.

AB - Stereotactic body radiation therapy (SBRT) has found an important role in the treatment of patients with non-small cell lung cancer, demonstrating improvements in dose distribution and even tumor cure rates, particularly for early-stage disease. Despite its emerging clinical efficacy, SBRT has primarily evolved due to advances in medical imaging and more accurate dose delivery, leaving a void in knowledge of the fundamental biological mechanisms underlying its activity. Thus, there is a critical need for the development of orthotropic animal models to further probe the biology associated with high-dose-per-fraction treatment typical of SBRT. We report here on an improved surgically based methodology for generating solitary intrapulmonary nodule tumors, which can be treated with simulated SBRT using the X-RAD 225Cx small animal irradiator and Small Animal RadioTherapy (SmART) Plan treatment system. Over 90% of rats developed solitary tumors in the right lung. Furthermore, the tumor response to radiation was monitored noninvasively via bioluminescence imaging (BLI), and complete ablation of tumor growth was achieved with 36 Gy (3 fractions of 12 Gy each). We report a reproducible, orthotopic, clinically relevant lung tumor model, which better mimics patient treatment regimens. This system can be utilized to further explore the underlying biological mechanisms relevant to SBRT and high-dose-per-fraction radiation exposure and to provide a useful model to explore the efficacy of radiation modifiers in the treatment of non-small cell lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=84976496788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976496788&partnerID=8YFLogxK

U2 - 10.1667/RR14382.1

DO - 10.1667/RR14382.1

M3 - Article

C2 - 27223828

AN - SCOPUS:84976496788

VL - 185

SP - 616

EP - 622

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 6

ER -